<?xml version="1.0" encoding="UTF-8"?>
<p>Another important dimension in this quest for repurposed drugs involves patent protection issues under current national and/or international regulations [
 <xref rid="B18" ref-type="bibr">18</xref>]. A global health emergency of this magnitude calls for a bold, international response at the governmental and political levels. Therefore, the regulatory community must act fast to minimize any financial hurdles implicating private industry and update guidelines for drug licensure through repurposing if necessary. It should not escape us that this is a vital behind-the-scene act while efforts are underway to seek new indications for existing compounds.
</p>
